Camilla Qvortrup

Camilla Qvortrup serves as a Clinical Associate Professor in the Department of Clinical Medicine within the Faculty of Health and Medical Sciences at the University of Copenhagen. Her clinical affiliation is with Region Hovedstaden (regionh.dk), Denmark's Capital Region healthcare system. She maintains an active research profile with 25 research outputs documented in the university repository, primarily focused on oncology with particular emphasis on gastrointestinal cancers.

Dr. Qvortrup's research interests center on colorectal cancer, immunotherapy approaches, precision medicine applications, and cancer biomarker development. Her work spans molecular oncology investigations including mismatch repair deficiency studies, BRAF/KRAS genetic testing implementation, and immunotherapy trials. She has made significant contributions to understanding prognostic biomarkers like CA19-9 and CEA in colorectal cancer patients, and has explored treatment adaptations for special populations including elderly patients with gastroesophageal cancer.

Her publication record demonstrates strong collaborative activity across Danish oncology research networks, with recent work appearing in high-impact journals including Annals of Surgery, Journal of Clinical Oncology, and JCO Precision Oncology. Her research shows a clear trajectory toward integrating molecular diagnostics with clinical treatment approaches, particularly in the colorectal cancer space. Notable projects include neoadjuvant immunotherapy trials for mismatch repair deficient colon cancer and multi-omics approaches to predict response to BRAF-targeted therapies.

Dr. Qvortrup participates in major clinical trials research, including the Phase III LEAP-017 study investigating lenvatinib plus pembrolizumab for metastatic colorectal cancer. Her work demonstrates translation from basic molecular research to clinical application, with particular attention to real-world implementation challenges in precision oncology.